Plandai Biotechnology Sets for Battle Against Neurological Diseases by using Nutraceuticals

Plandaí­ Biotechnology, Inc. (OTCQB: PLPL) transforming the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. These extracts are utilized to deliver a new family of drugs to safely and cost effectively treats a plethora of different diseases and conditions.

Read more »

Opexa Shares Soar on Multiple Sclerosis Trial Data

Opexa Therapeutics announced that 83 percent of clinical trial patients taking its therapeutic vaccine Tovaxin remained relapse-free for a year.

Read more »

Biogen Idec, Electro-Optical Among “5 Stocks Approaching Greatness”

Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.

Read more »

[Company Profile] Reata Pharmaceuticals

According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood.

Read more »